Arbutus Biopharma Corp Common Stock, Capital Shares Reserved for Future Issuance
Arbutus Biopharma Corp (ABUS) had Common Stock, Capital Shares Reserved for Future Issuance of 554.17 thousand shares as of 2025-12-31, per its 10-K filed 2026-03-23.
Financial Statements › Notes
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2026-03-23
- 2025-12-31: Common Stock, Capital Shares Reserved for Future Issuance 554.17K shares.
- 2024-12-31: Common Stock, Capital Shares Reserved for Future Issuance 614.67K shares.
- 2023-12-31: Common Stock, Capital Shares Reserved for Future Issuance 842.00K shares.
- 2022-12-31: Common Stock, Capital Shares Reserved for Future Issuance 1.13M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance |
|---|---|
| 2025-12-31 | 554.17K shares 10-K · filed 2026-03-23 |
| 2024-12-31 | 614.67K shares 10-K · filed 2025-03-27 |
| 2023-12-31 | 842.00K shares 10-K · filed 2024-03-05 |
| 2022-12-31 | 1.13M shares 10-K · filed 2023-03-02 |
| 2021-12-31 | 1.30M shares 10-K · filed 2022-03-03 |
| 2008-05-30 | 350.46K shares 10-K · filed 2015-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |